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Astrocytes interact dynamically with neurons by modifying synaptic activity and plasticity. This interplay occurs through a process
named gliotransmission, meaning that neuroactive molecules are released by astrocytes. Acting as a gliotransmitter, D-serine, a co-
agonist of theNMDAreceptor at the glycine-binding site, can be released by astrocytes in a calcium [Ca2]i-dependentmanner. A typical
feature of astrocytes is their high expression level of connexin43 (Cx43), a protein forming gap junction channels and hemichannels
associated with dynamic neuroglial interactions. Pharmacological and genetic inhibition of Cx43 hemichannel activity reduced the
amplitude ofNMDAEPSCs inmouse layer 5 prefrontal cortex pyramidal neuronswithout affectingAMPAEPSC currents. This reduction
of NMDA EPSCs was rescued by addition of D-serine in the extracellular medium. LTP of NMDA and AMPA EPSCs after high-frequency
stimulationwas reducedbyprior inhibitionofCx43hemichannel activity. InactivationofD-serine synthesiswithin the astroglial network
resulted in the reduction of NMDA EPSCs, which was rescued by adding extracellular D-serine. We showed that the activity of Cx43
hemichannels recorded in culturedastrocyteswas [Ca2]I dependent.Accordingly, in acute cortical slices, clamping [Ca
2]i at a low level
in astroglial network resulted in an inhibition of NMDA EPSC potentiation that was rescued by adding extracellular D-serine. This work
demonstrates that astroglial Cx43 hemichannel activity is associated with D-serine release. This process, occurring by direct permeation
of D-serine through hemichannels or indirectly by Ca2 entry and activation of other [Ca2]i-dependent mechanisms results in the
modulation of synaptic activity and plasticity.
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Introduction
An important step in establishing the occurrence of dynamic
neuroglial interactions has been the demonstration that glial cells
can deliver neuroactive molecules called “gliotransmitters” that
affect neurotransmission (Kettenmann and Zorec, 2013). These
gliotransmitters include neurotransmitters (ATP, glutamate), ei-
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Significance Statement
Werecordedneuronal glutamatergic (NMDAandAMPA) responses in prefrontal cortex (PFC) neurons andused pharmacological and
genetic interventions to block connexin-mediated hemichannel activity specifically in a glial cell population. For the first time in astro-
cytes, we demonstrated that hemichannel activity depends on the intracellular calcium concentration and is associated with D-serine
release. Blocking hemichannel activity reduced the LTP of these excitatory synaptic currents triggered by high-frequency stimulation.
These observationsmay be particularly relevant in the PFC, whereD-serine and its converting enzyme are highly expressed.
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cosanoids, lactate, and the cytokine tumor necrosis factor alpha,
which can be released from astrocytes through several pathways.
D-serine is another interesting gliotransmitter that is also re-
leased by astrocytes (Martineau et al., 2008) and acts as an agonist
at the glycine site of NMDARs in neurons (Mothet et al., 2000;
Martineau et al., 2006; Wolosker, 2007), playing important roles
in glutamatergic transmission and synaptic plasticity (Mothet et
al., 2005; Panatier et al., 2006; Fossat et al., 2012; Papouin et al.,
2012). Interestingly, memory processes rely on the capacity to
express functional plasticity, notably long-lasting changes in syn-
aptic strength driven by NMDAR activation (Morris, 2013), and
it has been shown that D-serine release from astrocytes, depen-
dent on their intracellular calcium concentration [Ca2]i, regu-
lates LTP in hippocampus (Henneberger et al., 2010). Initially, in
vitro and immunohistochemical studies suggested that serine-
racemase, the L- toD-serine-converting enzyme, was found only
in astrocytes, which were therefore considered as the main
source ofD-serine in the brain (Schell et al., 1995;Wolosker et al.,
1999).However,more recent studies indicate aneuronal expression
of serine racemase (Miya et al., 2008;Ding et al., 2011; Ehmsen et al.,
2013;Wolosker et al., 2016). Therefore, it is now accepted that both
cell types produce and use D-serine as a key signaling molecule
(Martineau et al., 2014).
It has been suggested that alterations in the extracellular
D-serine level leads to neurological and psychiatric disorders
(Martineau et al., 2014). In this context, the prefrontal cortex
(PFC) is thought to be involved in the physiopathological devel-
opment of schizophrenia because hypofunction of the PFC (Tan
et al., 2007) and altered glutamatergic transmission have been
observed in subjects with schizophrenia (Lewis et al., 2003; Poels
et al., 2014). So far, deficits in glutamatergic transmission have
been considered to bemostly of neuronal origin.However, recent
studies suggest that astrocytes could also contribute to the control
of glutamatergic synaptic transmission (Bernardinelli et al.,
2014). D-serine has been showed to be released by astrocytes after
[Ca2]i-dependent vesicular fusion of either large (Kang et al.,
2013) or small synaptic-like vesicles (Bezzi et al., 2004;Martineau
et al., 2008, 2013), but it is not excluded that alternative nonve-
sicular pathways may be involved. One such mechanism consists
of the opening of connexin (Cx) hemichannels, which may also
contribute to D-serine release either directly as a pathway for
diffusion or indirectly by facilitating Ca2 entry that subsequently
activates other [Ca2]i-dependent D-serine release mechanisms.
Indeed, in the brain, astrocytes express a large amount of these
gap junction proteins (Giaume et al., 2013). Interestingly, Cx43
hemichannel activity has already been associated with the release
of gliotransmitters such as glutamate and ATP (Ye et al., 2003;
Kang et al., 2008; Stehberg et al., 2012), leading to themodulation
of synaptic transmission in hippocampus (Chever et al., 2014;
Abudara et al., 2015) and olfactory bulb (Roux et al., 2015).
In the present study, we investigatedwhetherCx43 hemichan-
nel activity is associated with D-serine release by PFC astrocytes
and thus affects neuroglial interaction and synaptic plasticity. For
this purpose, we recorded NMDA and AMPA EPSCs in pyrami-
dal neurons and used pharmacological and genetic interventions
to suppress Cx43 hemichannel activity in astrocytes. We were
able to show that the [Ca2]i- and serine racemase-dependent
release of D-serine from astrocytes affected NMDA EPSCs. The
latter were decreased by preventing Cx43 hemichannel activity in
astrocytes andwere rescued by addition of extracellular D-serine.
Although the intimate release mechanism from astrocytes was
not a focus of our investigation, we showed that inhibition of
Cx43 hemichannel activity impacted synaptic plasticity because it
reduced LTP of NMDA and AMPA EPSCs triggered by high-
frequency stimulation (HFS).
Materials andMethods
Experiments
All experiments were performed according to the European Community
Council Directives of January 1, 2013 (2010/63/EU) and followed the
Institut National de la Sante´ et de la Recherche Me´dicale (INSERM)
guidelines for the ethical treatment of animals. Experiments were also
done in accordance with institutional French (Comite´ Ope´rationnel
pour l’Ethique dans les Sciences de la Vie du Centre National de la Re-
cherche Scientifique, CNRS) and international (National Institutes of
Health) standards and legal regulations (Ministe`re de l’Agriculture et de
la Peˆche) for the use and care of animals. All efforts were made to mini-
mize the number of animals used and their suffering.
Animals
Wild-type and transgenic hGFAP-eGFP mice with astrocytes expressing
the enhanced green fluorescent protein (eGFP) under the control of a hu-
man glial fibrillary acidic protein (hGFAP) promoter (Nolte et al., 2001)
were used as controls. To assess astroglial Cx functions, we used the Cx43 fl/fl:
GFAP-cre (Cx43 KO) mouse line to selectively knock out Cx43 in astro-
cytes (Theis et al., 2003). Mice of either sex were used in this study.
Cell cultures
Astrocytes in culturewere prepared from the cortex of newbornC57BL/6
mice as described previously (Meˆme et al., 2006). Briefly, the cortices
were dissected, their meninges were peeled off, and the tissue was me-
chanically dissociated in PBS supplemented with D-glucose (33 mM).
Cells were seeded on poly-ornithine-coated 100-mm-diameter plastic
dishes at a density of 2  106 cells/dish in DMEM supplemented with
penicillin (10 U/ml), streptomycin (10 g/ml; Invitrogen), and 10%
FCS.When cells had reached confluence, 1M cytosine-arabinoside was
added to the culture medium for 3 d to prevent microglia proliferation.
Medium was changed twice a week and secondary cultures were used
after 1 week. Secondary astrocyte cultures were obtained by harvesting
subconfluent 1-week-old primary cultures with trypsin-EDTA and plat-
ing on poly-ornithine-coated 14-mm-diameter glass coverslips (1.5 
105 cells) in the same culture conditions.
Measurement of hemichannel activity in cultured astrocytes
Dye uptake in cultured astrocytes. Ethidium bromide (EtBr, 314 Da) up-
take was measured in cultured astrocytes in control conditions and after
treatment with the Ca2 ionophore ionomycin (1 M). Cultured astro-
cyteswere preincubated in standardHEPESbuffer containing the follow-
ing (in mM): NaCl 150, KCl 5.4, MgCl2 1, CaCl2 2, HEPES 5, and
D-glucose 10, pH adjusted to 7.4. Cells were maintained either in the
standard solution or in the presence of carbenoxolone (CBX, 50 M) or
Gap26 peptide (100 M) for 5 min and then exposed to 5 M EtBr for
10min at room temperature (RT). Cells were then washed with the same
buffer and fixed with 4% paraformaldehyde in PBS. Fixed cells were
examined at 40with a confocal laser-scanningmicroscope (Leica SP5).
Stacks of 10 consecutive confocal images taken at 0.5 m intervals were
acquired. Six images were captured for each experimental condition per
animal. Images of EtBr uptake were analyzed with ImageJ.
Electrophysiological recordings of hemichannel currents in cultured
astrocytes. Secondary astrocyte cultures were harvested by trypsin-EDTA
and replated on glass coverslips for at least 3 h before electrophysiological
recordings. This treatment yields round-shaped solitary astrocytes for
subsequent whole-cell recording experiments. The bath solution was
composed of the following (in mM): NaCl 130, CsCl 10, MgCl2 1, CaCl2
1.8, HEPES 10, pH 7.4; the pipette solution contained the following (in
mM): CsCl 130, Na-aspartate 10, CaCl2 0.26, MgCl2 1, EGTA 2, tetraeth-
ylammonium (TEA)-Cl 7, and HEPES 5, pH 7.2. Pipette [Ca2] was
50 nM as calculated with Webmax software (http://www.stanford.edu/
~cpatton/webmaxcS.htm), the composition of the 200 nM pipette [Ca2]
solution was calculated with the same software. Single-channel currents
were recorded with an EPC 7 PLUS patch-clamp amplifier (HEKA Elec-
tronik). The holding potential was80mVandpulse duration of voltage
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steps to various potentials was 15 s long. Volt-
age ramp stimulation ranged from70 to70
mV and was applied over a 10 s time period.
Currents were filtered by a 7-pole Bessel low-
pass filter at 1 kHz cutoff frequency. Data were
digitized at 2 kHz using a NI USB-6221 data
acquisition device (National Instruments) and
WinWCP acquisition software designed by Dr.
J. Dempster (University of Strathclyde, UK).
Hemichannel membrane charge transfer (Qm)
was calculated by integrating the unitary cur-
rent traces over the duration of the voltage step
as follows:
Qm  idt
Electrophysiology recordings in acute
cortical slices
Slice preparation and recording conditions. Mice
from postnatal day 21 (P21) to P28 (P0 being
the day of birth) were killed by decapitation
and the PFC was rapidly dissected in ice-cold
oxygenated (95% O2–5% CO2) solution con-
taining the following (in mM): NaCl 83,
NaHCO3 26.2, NaH2PO4 1, KCl 2.5, MgSO4
3.3, CaCl2 0.5, sucrose 70, and D-glucose 22,
pH 7.3, 315 mOsm. Coronal slices (250 m)
were cut in the same solution using a vi-
bratome (Microm HM 650V; Thermo Fisher),
incubated for 30 min at 34°C in the standard
artificial CSF solution (ACSF) and stored at
room temperature until use. All solutions were perfused continuously
and oxygenated with a mixture of 95%O2 and 5% CO2. Slices were then
placed in a submerged recording chamber mounted on an upright mi-
croscope (Zeiss Axioskop FS) equipped for infrared differential interfer-
ence contrast microscopy and epifluorescence. They were perfused
continuously with the standard oxygenated ACSF containing the follow-
ing (in mM): NaCl 124, NaHCO3 26, KCl 3, NaH2PO4 1.25, MgCl2 1.3,
CaCl2 2, andD-glucose 20, pH 7.4 at RT at 2ml/min.Whole-cell voltage-
clamp recordings for pyramidal neurons were performed with borosili-
cate glass pipettes (3–5 M in bath) containing the following (in mM):
Cs-methylsulfonate 115, HEPES 10, ATP 4, CsCl 20, GTP 0.4, EGTA 10,
adjusted to pH 7.4 with CsOH, 281 mOsm. Whole-cell voltage-clamp
recordings of astrocytes were performed with borosilicate glass pipettes
(6–7 M in bath) containing the following (in mM): K-gluconate 105,
KCl 30, HEPES 10, phosphocreatine 10, ATP-Mg 4, GTPTris 0.3, and
EGTA 0.3, pH 7.4, adjusted to pH 7.4 with KOH, 290 mOsm. In Ca2-
clamp experiments, 0.45mMEGTAand 0.14mMCaCl2were added to the
control intracellular astrocyte solution to maintain intracellular free
CaCl2 at a steady-state concentration of 50–80 nM (calculation by Web-
MaxChelator; adapted from Henneberger et al., 2010). When required,
the currently most effective serine racemase inhibitor L-erytho-3-
hydroxyaspartate (HOAsp) (WakoChemicals;Ki 49M)was added to
the astrocyte intracellular solution (Strisovsky et al., 2005). Whole-cell
currents were recorded with a MultiClamp 700B amplifier (Molecular
Devices), sampled with a Digidata 1322A Interface (10 kHz sampling, 2
kHz filtering), and the analysis was performed with pClamp9 software
(Molecular Devices). Series resistances were compensated at 80% for
pyramidal cells and astrocytes. Input resistance wasmeasured in voltage-
clamp mode by applying hyperpolarizing voltage pulses (10 mV, 150
ms) from a holding potential of 60 mV for pyramidal neurons and
from a holding potential of 80 mV for astrocytes. Only pyramidal
neurons with a restingmembrane potential more negative than55mV
and astrocytes with a resting membrane potential more negative than
75mVwere kept for further analysis. Access resistance of the recording
pipette was tested at the beginning and the end of each experiment, all
recordings with an access resistance (Ra)  25 M or 20% change
between the beginning and the end of the experiment were excluded
from analysis. Electrical stimuli (1–10 A, 0.2 ms duration) were deliv-
ered (ISO-Flex A.M.P.I.) extracellularly in layer 2–3 (L2–3) using 1 M
glass electrodes filled with the external solution described above. The
stimulation intensity corresponded to 50% of the maximum response.
For analysis, at least five consecutive traces were averaged.
Dye coupling experiments in astrocytes
Cells were identified as astrocytes based first on their morphology and
second on electrophysiological properties (see above). The pipette (3–8
M) solution contained the following (inmM): K-gluconate 105, KCl 30,
HEPES 10, phospho-creatine Tris 10, ATP-Mg2 4, GTP-Tris 0.3, EGTA
0.3, adjusted to pH 7.4 with KOH, and sulforhodamine B (1 mg/ml; 559
Da; Invitrogen). Input resistance (Rin) was measured in voltage-clamp
mode by applying hyperpolarizing voltage pulses (10 mV, 150 ms) from
a holding potential of80 mV. To assess the level of gap junction cou-
pling, sulforhodamine B was added to the pipette solution before each
experiment. Recorded cells were loaded passively with the dye for 10min
in current-clamp mode. The duration of the whole-cell recording was
kept constant to allow comparison among experiments. Intercellular dif-
fusion of sulforhodamine B was captured thereafter with the CCD cam-
era (Pixelfly QE; Cook) on different focal planes and the number of
surforhodamine B-positive cells (i.e., cells dye coupled to the recorded
astrocyte) was determined using ImageJ software (Liu et al., 2013).
Recording of NMDAandAMPA synaptic currents in pyramidal neurons.
NMDA EPSCs were recorded in response to electrical stimulation of
L2–3 after blockade of GABAA receptors by picrotoxin (100 M) and
AMPA receptors by NBQX (10 M) at a holding potential of 40 mV.
The NMDA EPSCs were abolished by the bath application of (2R)-
amino-5-phosphonovaleric acid (D/L-AP5, 50M), anNMDAR blocker
(see Fig. 2A1). AMPA EPSCs evoked by L2–3 electrical stimulation were
also recorded at a holding potential of70mV in presence of picrotoxin
(100 M), a GABAA receptor blocker, and D/L-AP5 (50 M) to block
NMDA EPSCs. The AMPA EPSCs were abolished by bath application
of2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione
(NBQX, 10 M), a selective blocker of AMPARs (data not shown). The
AMPA/NMDA ratio was measured in the same cell in the presence of
picrotoxin but in the absence of NBQX.
Plasticity induction protocol. After a control period (15 min), an HFS
protocol was elicited in L2–3 of the PFC with theta-burst stimulation
(3 trains of 13 bursts applied at 5 Hz frequency, each burst containing 4
Figure 1. A, Illustration of experimental arrangement and astrocyte properties in PFC slices from hGFAP-eGFP mice. One
pyramidal cell in L5 was loaded with biocytin (red; 1 mg/ml) during whole-cell recording in PFC acute slices, whereas several
astrocytes expressedeGFP (green). Stimulationelectrodewasplaced in L2/3anddual recordingof anastrocyte andapyramidal cell
was performed in L5. The average distance between the stimulating electrode and the soma of the recorded L5PCwas300m.
B, Confocal imageof a representative eGFP-positive astrocyte in L5of thePFC. Scale bars, 100, 100, and25m, respectively.C, Dye
coupling in L5 of the PFC. An eGFP-positive astrocyte was recorded for 10 min in whole-cell configuration with a patch pipette
containing sulforhodamide B (1 mg/ml) that diffused in neighboring cells through gap junction channels.
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pulses at 100Hz, for a total duration of 2min). Then, recording of current
responses in pyramidal neurons were performed after the end of the HFS
protocol to be comparedwith the control recording.Themeanamplitudeof
NMDA and AMPA EPSCs was measured 30 min after HFS protocol
induction.
Confocal imaging of PFC acute slices. After loading pyramidal cell in
L5 with biocytin (1mg/ml; Sigma-Aldrich) in thePFC, acute slicewas fixed
in 4% PFA overnight at 4°C. Fixed PFC slices from 1-month-old hGFAP-
eGFP mice were examined with a confocal laser scanning microscope SP5
(Leica).Tovisualize the entire lengthof apyramidal cell fromL5 loadedwith
biocytin (1 mg/ml; Sigma-Aldrich) revealed by Alexa Fluor 555-conjugated
steptavidin, 5 images covering L1–5 of the PFC were captured with a 20
objective. Stacks of 30 consecutive confocal opti-
cal sections at 1 m intervals were acquired se-
quentially (with 2 lasers 488 and 560 nm) and Z
projections were reconstructed using Leica con-
focal software. Then, one image was recon-
structed using the photomerge function of
Adobe Photoshop software. To visualize the
morphology of one astrocyte expressing eGFP, a
stack of 30 optical sections taken at 0.5m inter-
vals were acquired with a 63 objective and Z
projection reconstructed.
Drugs and peptides
The following drugs were used in this study:
the mimetic peptide Gap26 (amino acid se-
quenceVCYDKSFPISHVR; purity,95%; 300
g/ml, 200 M; Thermo Fisher Scientific) and
a scrambled peptide containing the same
amino acids as the Gap26 (amino acid se-
quence PSFDSRHCIVKYV; purity,95%; 300
g/ml, 200 M; Thermo Fisher Scientific). To
avoid peptide degradation, peptides were di-
luted in oxygenated ACSF 2 min before appli-
cation on the slices. To test the impact on Cx43
hemichannel function, analysis was performed
within the first 10–15 min of recording after
peptide exposure except for the LTP experi-
ments. All chemicals used for electrophysiology
experiments were obtained from Sigma-Aldrich
except for D/L-AP5, NBQX, Ro 25–6981 male-
ate,D-serine, and 7-chlorokynurenic acid, which
were purchased from R&D Systems.
Statistical analysis
For each data group, results are expressed as
mean 	 SEM and n refers to the number of
independent experiments. Unpaired one-
tailed student test was used. Differences are
considered significant at *p 
 0.05, **p 

0.01, and ***p 
 0.001. GraphPad Prism 5
softwarewasused for calculations.One-wayvari-
ance analysis on ranks with Dunn’s post test was
used formultiple comparisons in thebarchartsof
Figure 5, E and F.
Results
Cx43 hemichannel activity in astrocytes
impacts NMDAR-mediated synaptic
currents recorded from pyramidal
neurons in prefrontal cortical slices
The involvement of Cx43 hemichannels
in the modulation of glutamatergic syn-
aptic currents was investigated in PFC L5
pyramidal cells (L5PCs) in response to
L2/3 stimulation (Fig. 1A–C). For this
purpose, we first used themimetic peptide
Gap26 (Chaytor et al., 1997) to specifi-
cally reduce Cx43 hemichannel function in astrocytes (Giaume et
al., 2013) from ex vivo PFC slice preparation. This mimetic pep-
tide contains an amino acid sequence found in the first extracel-
lular loop of Cx43 and its interaction with Cx43 prevents
hemichannel opening in astrocytes as shown previously by dye
uptake assays (Retamal et al., 2007; Chever et al., 2014; Abudara
et al., 2015) and electrophysiological recording of Cx43-
transfected cells (Desplantez et al., 2012; Wang et al., 2012). At 2
weeks of age, Cx43 is not expressed by neurons (Nagy and Rash,
2000; Genoud et al., 2015), microglial cells, or cells of the oligo-
Figure2. Inhibitionof Cx43hemichannel activity inastrocytes affectsNMDAEPSCs in thePFC.A1,A2, EPSCs (averaged fromfive
consecutive traces) generated by stimulation in L2/3were recorded, in the presence of picrotoxin (100M) in pyramidal cells from
L5 held at 40mV or70mV to isolate NMDA and AMPA EPSCs, respectively. Scale bars, 100 pA and 100ms. A1, Typical NMDA
andAMPAEPSCs in control condition.A2, Typical NMDAandAMPAEPSCs in presence of Gap26.B1,B2, Differential effect of Gap26
(200M) on the amplitudeof AMPA (B1) andNMDA (B2) EPSCs. Note that therewasno significant differencebetween control and
Gap26 for AMPA currents ( p 0.05, t test, n 7),whereas the amplitude of NMDA currentswas significantly reduced ( p
 0.05,
t test, n 7). C, Mean of NMDA EPSC amplitude in control conditions and in presence of Gap26.D, Quantification of AMPA/NMDA
ratio under the indicated conditions. The AMPA/NMDA ratio was significantly increased in Cx43 KOmice ( p
 0.05, t test, n 7)
and in presence of Gap26 ( p
 0.05, t test, n 7), whereas the Gap26 scramble peptide had no effect ( p 0.05, t test, n 7).
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dendroglial lineage (Nagy and Rash, 2000); therefore, the appli-
cation of Gap26 is expected to target hemichannels in astrocytes
selectively. We first looked at glutamatergic postsynaptic re-
sponses triggered by L2/3 stimulation and isolated excitatory
AMPA and NMDA currents by recording them at two holding
potentials,70 and40 mV, respectively, in presence of picro-
toxin (Fig. 2A1,A2). In such conditions, we observed that the
acute application of Gap26 (200 M) had no effect on the AMPA
EPSC amplitude (p 0,05, t test, n 7; Fig. 2A2,B1). In contrast,
the average NMDAEPSC amplitude was significantly reduced by
Gap26 (22	 3%, p
 0.05, t test, n 7; Fig. 2A2, B2,C), leading
to a significant increase of theAMPA/NMDAratio (24	 4%; p

0.05, t test, n  7). Control experiments using the scrambled
Gap26 peptide (200 M) showed no effect on the AMPA/NMDA
ratio (p 0.05, t test, n 7). Finally, we found that the AMPA/
NMDA ratio was also significantly higher in wild-type than in
Cx43 fl/fl:GFAP-cre (Cx43 KO) cortical slices (22	 3%; p
 0.05,
t test, n 7; Fig. 2D). Altogether, these observations indicate that
Cx43 hemichannel activity in astrocytes affects glutamatergic
transmission by reducing specificallyNMDA synaptic currents in
L5PCs of the PFC.
NMDA synaptic currents are modulated by D-serine release
associated with Cx43 HC activity in astrocytes
We next aimed at determining whether the reduction in NMDA
currents due to Cx43 hemichannel activity was linked to glio-
transmission. Indeed, because Gap26 did not affect AMPA cur-
rents yet NMDA currents were reduced and because astrocytes
represent a potential source for D-serine (Gundersen et al.,
2015), we hypothesize that Cx43 hemichannel activity may be
involved in the process of D-serine release by astrocytes. First, the
NMDAnature of currents recorded at40mVwas confirmed by
its complete blockade (95	 4%; n 7, t test, p
 0.001) in the
presence of D/L-AP5 (50 M), an NMDAR blocker (Fig. 3A1,B).
Second, we tested the effect of several concentrations of D-serine
on NMDA EPSCs in presence of Gap26 (Fig. 3B). In this set of
experiments, we observed as indicated above that bath applica-
tion of Gap26 (200M) induced a significant decrease of NMDA
EPSCs (23	 3% of control; p
 0.05, t test, n 9). This inhibi-
tion was not rescued by 5 M D-serine (p 0.05, t test, n 7),
whereas 10 and 100 M D-serine were found to reverse the effect
of Gap26 (p
 0.05, t test, n 6 and 7, respectively; Fig. 3A2,B).
As awhole, these results suggest thatD-serine release is correlated
to Cx43 hemichannel activity in astrocytes and thus contributes
to modulate NMDA EPSCs in L5PCs of the PFC.
Cx43 hemichannel activity is controlled by intracellular Ca2
concentration in cultured astrocytes
Calcium signaling in astrocytes involves complex pathways that
participate in neuroglial interaction dynamics (Scemes and Gi-
aume, 2006; Khakh and McCarthy, 2015; Bazargani and Attwell,
2016). Cx43 hemichannels have been demonstrated to open with
a modest increase of the intracellular Ca2 concentration
([Ca2]i); upon further increasing [Ca
2]i (500 nM), the chan-
nels close again, resulting in a bell-shaped “convex-up” response
curve (De Vuyst et al., 2009; Wang et al., 2012; Bol et al., 2017).
However, most of these properties were obtained from cell
expression systems or cardiomyocytes; here, we determined
whether astroglial Cx43 hemichannels could also be activated by
[Ca2]i elevation. We first tested whether increasing [Ca
2]i ac-
tivated endogenous Cx43 hemichannels in cultured astrocytes by
using the EtBr uptake assay taken as an index of hemichannel
activity (Giaume et al., 2012). As illustrated in Figure 4, treatment
of Fluo-4/AM-loaded astrocytes with ionomycin (1M) elicited a
rapid increase in [Ca2]i that reached a plateau after 90 s (Fig.
4B). In such conditions, we observed that EtBr uptake was in-
creased by 102	 14% (p
 0.05, one-way ANOVAwith Tukey’s
test, n  3) in the presence of ionomycin and that EtBr uptake
returned to basal level when either CBX (50 M) or Gap26
(200 M) was added in presence of ionomycin (Fig. 4A1–A3,C).
These results indicate that an increase of [Ca2]i in astrocytes
activates Cx43 hemichannels.
We next performed patch-clamp experiments on single astro-
cytes isolated from astrocyte cell cultures and recorded in whole-
cell mode, allowing control of [Ca2]i by changing the Ca
2
concentration in the pipette solution. In the control 50 nM
[Ca2]i condition, voltage steps from a holding potential of80
mV to a range of potentials up to 50 mV did not trigger any
hemichannel opening activity (Fig. 5A). With [Ca2]i set to
200 nM, clear current activities appeared in the traces. Activities
were most prominent at50 mV as observed in other cell types
(Wang et al., 2012). Interestingly, single-channel opening events
were also observed at potentials in the70 to30mVrange (Fig.
5A). Absence of unitary current activity at 50 nM [Ca2]i and its
appearance at both negative and positive potentials with 200 nM
[Ca2]i were also observed when electrical stimulation was done
with voltage ramps (Fig. 5B). The presence of single channel ac-
tivities at negative and positive voltages allowed us to construct
Figure 3. Modulation of NMDA EPSCs in pyramidal cells by D-serine involves astrocyte he-
michannel activity.A1,A2, Typical recordingofNMDAEPSCs at40mV (scale bars, 100pAand
100ms) inpresenceof picrotoxin (100M) andNBQX (10M).A1, NMDAEPSCs (averaged from
5 consecutive traces)were abolished by the NMDARblocker D/L APV ( p
 0.001, t test, n 7).
A2, NMDA EPSCs were significantly decreased in presence of Gap26 ( p
 0.05, t test, n 9)
and this effect was rescued by adding D-serine (100M) to the extracellular solution. B, Graph
summarizing the relativeNMDAEPSCamplitudeof the samples shown inAandBand for several
concentration of D-serine in the external solution. Note that the rescue of Gap26 inhibitory
effect became statistically significant for 10 and 100M D-serine ( p
 0.05, t test, n 7).
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an I–V plot of unitary current amplitudes, which was character-
ized by a slope conductance of 230 pS, a typical value for
the single-channel conductance of Cx43 hemichannels (Fig. 5C).
We next constructed all point histograms of unitary current ac-
tivities at negative (70 to 30 mV) and positive potentials
(30 to50mV). These graphs (Fig. 5D) demonstrated a single-
channel conductance in the range of the slope conductance ob-
tained from the I–V plot (Fig. 5C). Importantly, Gap26 (200M)
inhibited the unitary current activities at negative and positive
potentials in the traces (Fig. 5A) and in the histograms (Fig. 5D).
We further quantified the inhibitory effect of Gap26 on unitary
current activities by calculating the charge transfer associated
with unitary hemichannel opening activity. Such analysis dem-
onstrated very low hemichannel charge transfer at 50 nM [Ca2]i,
which was significantly increased at 200 nM [Ca2]i and was
reduced to baseline level by Gap26 for both positive and negative
voltages (see Fig. 5E for data at 70 mV and Fig. 5F for data at
50 mV). The traces of the voltage-ramp experiments shown in
Figure 5B suggest that Gap26 also affects the current with unre-
solved unitary components. To determine whether such effect is
consistent, we verified whether Gap26 influences the clamping
current at a given command voltage. At50 mV, Gap26 indeed
significantly inhibited the clamping current (50 nM [Ca2]i:
166	 37 pA, 200 nM [Ca2]i: 263	 42 pA and 200 nM [Ca
2]i
Gap26: 123	 27 pA; n 6; p
 0.05 one-way ANOVA), whereas
there were no significant differences at70 mV (50 nM [Ca2]i:
82.8 	 33 pA, 200 nM [Ca2]i: 81.1 	 20 pA and 200 nM
[Ca2]i  Gap26: 80.9 	 33 pA; n  6). The Gap26 effect at
50 mVmay result from long hemichannel opening events (not
associated with channel transition events during the time win-
dow of the recording), which require a significant increase in the
clamping current.
Clamp of [Ca2]i and inhibition of
hemichannel activity in astrocytes
reduce LTP of NMDA and AMPA
synaptic currents in the PFC
Several studies have pointed out the
importance of hippocampal astrocyte
[Ca2]i signaling in regulating D-serine
release and LTP (Henneberger et al., 2010;
Kang et al., 2013). However, the implica-
tion of astrocyte [Ca2]i in LTP remains
under discussion (Bazargani and Attwell,
2016). Because we have demonstrated
that increasing [Ca2]i activates Cx43 he-
michannels in astrocytes, we decided to
test in the PFC whether their activation
plays a role in LTP ofNMDAREPSCs. For
this purpose, we recorded NMDAR
EPSCs in response to a HFS protocol in
L5PCs and clamped [Ca2]i in astrocytes.
To achieve the [Ca2]i clamp in the astro-
glial network, we used a previously re-
ported intrapipette solution with EGTA
and 50–80 nM Ca2 (Henneberger et al.,
2010) and a dual recording with a L5PC
and a neighbor astrocyte from eGFP-
hGFAPmice. A recent study (DeNardo et
al., 2015) indicates that, in the mouse at
the age studied, PFC L2/3 (where the
stimulating electrodewas located; Fig. 1A)
provides a major source of excitatory in-
puts to L5 (where the patched pyramidal
neuron and the astrocyte were located; Fig. 1A). This presumably
concerns the soma and the proximal dendrite of the pyramidal
cells. In addition, the extent of dye coupling (studied with
sulforhodamine B) between astrocytes was 53 	 3 cells (n 
10) after 10 min of whole-cell recording (Fig. 1B) and the
averaged diameter size of an astrocyte domain was 58	 1 m
(n  12) based on measurements of eGFP-positive astrocytes lo-
cated in L5 (Fig. 1C). Therefore, taking into account these features,
we considered that after 30minofdual recording, the [Ca2]i clamp
in astrocyteswas achieved inL5 astrocytes thatwere in the vicinity of
L5PC synapses activated by the stimulation of input coming from
L2/3.
HFS is known to induce important glutamate release and to
potentiate AMPA and NMDA EPSCs (Nicoll and Schmitz, 2005)
such that LTP of NMDAR EPSCs is observed in response to HFS
both in the hippocampus (Harney et al., 2006) and in the PFC
(Zhao et al., 2005). First, we separately recorded in voltage-clamp
mode NMDA EPSCs at 40 mV or AMPA EPSCs at 70 mV
before and after applying a HFS protocol in L2/3 of the PFC (see
Materials and Methods). This procedure induced a persistent
potentiation of NMDA and AMPA EPSCs that lasted at least
40 min (Figs. 6,7, respectively). NMDA and AMPA EPSCs were
measured 30 min after HFS because it has been reported that
Gap26 starts to have an effect on gap junction communication
after 30 min exposure in HeLa cells (Desplantez et al., 2012) and
hours in C6 glioma cells (Decrock et al., 2009). In these condi-
tions, NMDA EPSCs were found to be significantly enhanced
(Fig. 6A1,B,C) by 48 	 5% compared with control before HFS
(p
 0.01, t test, n 7). However, when the [Ca2]i-clamp of the
astroglial network was performed before the HFS protocol, po-
tentiation of NMDA EPSCs compared with control before the
HFS was not significantly induced (18 	 5% of potentiation
Figure4. Activationof Cx43hemichannel in cultured cortical astrocytes is Ca 2dependent.A1–A3, Fluorescent imagesof EtBr
uptake in cultured astrocytes in control condition (CTL), after treatment with ionomycin (1M), and after treatment with iono-
mycin plus CBX (50M). Scale bar, 5m. Note that, whereas in control conditions, the uptake of EtBr was not observed (A1), it
became detected in the presence of the Ca 2 ionophore ionomycin (1M; A2) and was prevented by adding CBX to ionomycin
(A3). B, Time-dependent increase in resting [Ca 2]i recorded in astrocytes loaded with Fluo-4/AM and treated with ionomycin.
Error bars indicatemean	 SD, n 100 astrocytes for the same experiment. C, Histogram showing EtBr uptake expressed as themean
fluorescence intensity per astrocyte nucleus in control and after treatment with ionomycin. The increase in EtBr uptake triggered by
ionomycinwas blocked by either CBX (50M) or Gap26 (100M; p
 0.05, Student’s t test,n 3 independent cultures).
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Figure 5. Patch-clamp experiments demonstrating Ca 2 activation of Cx43 hemichannels in cortical astrocytes. A, Example traces of unitary current recordings at 50 (left) and 200 nM (middle)
[Ca 2]i with voltage steps from80mV to the potentials indicated at left (15 s voltage steps). Current activity is apparent at50mV but also in the70 to30mV range (activities shown at
larger scale for50and70mV). Gap26 (200M) clearly inhibited current activities (right).B, I–Vplot demonstratingmacroscopic current traces obtained fromvoltage-rampexperiments (70
to70 mV, 10 s). C, I–V plot of unitary current amplitudes from voltage-step experiments as shown in A, demonstrating a single-channel slope conductance of (Figure legend continues.)
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compared with the LTP control, p  0.05, t test, n  7;
Fig. 6A2,B,C). Interestingly, a similar effect was observed when
the HFS protocol was performed in the presence of Gap26 (200
M; 21	 7% potentiation compared with the LTP control, p
0.05, t test, n 7). Indeed, in the presence of themimetic peptide,
LTP of NMDA EPSCs was not significantly induced (Fig.
6A2,B,C). In both cases,NMDAcurrentswere not potentiated by
HFS, as already reported for LTP in the hippocampus for the
[Ca2]i-clamp condition (Henneberger et al., 2010). Moreover,
Gap26 had no additive effect when the HFS was applied after
establishing the [Ca2]i-clamp in the astroglial network (Fig.
6A3,B,C; p  0.05 compared with the
condition of [Ca2]i-clamp after HFS, t
test, n  8). We also recorded AMPA
EPSCs at a holding potential of 70 mV
and found that, after HFS, they were also
significantly enhanced (Fig. 7A1,B,C) by
44 	 4% compared with control (p 

0.01, t test, n 5) and that the change in
AMPA EPSCs amplitude was not signifi-
cant in the presence of Gap26 (200 M;
22	 4% potentiation compared with the
LTP control, p 0.05 comparedwithHFS
control, t test, n 5). In addition, AMPA
currents were not modified in the pres-
ence of the Gap26 scramble peptide (Fig.
6B,C). Altogether, these results indicate
that LTP in the PFC is dependent on as-
trocyte [Ca2]i, as already reported for
LTP in the hippocampus for the [Ca2]i
clamp (Henneberger et al., 2010) and on
Cx43 hemichannel activity in astrocytes.
Finally, we tested whether a selective
[Ca2]i increase in astrocytes could affect
the amplitude of NMDA EPSCs. For this
purpose, we used endothelin-1, the recep-
tors of which are highly expressed in as-
trocytes and weakly in neurons between
P1 and P30 (Andersson et al., 2007) and
the activation of which triggers a pro-
longed [Ca2]i elevation in astrocytes
(Venance et al., 1998; Blomstrand et al.,
1999) with no direct action on neuronal
activity (Fiacco et al., 2007; Agulhon et al.,
2010). When we applied endothelin-1 (10
nM), we observed that the averaged ampli-
tude of NMDA EPSCs had a tendency to
increase (5	 1% compared with control,
p  0.4, t test, n  5), although this was
not statistically significant (data not
shown).
D-serine release associated with hemichannel activity in
astrocytes modulates the potentiation of NMDA synaptic
currents in the PFC
We investigated whether D-serine release was associated with an
increase in hemichannel activity in astrocytes during the LTP
protocol. To determine whether D-serine produced by astrocytes
was involved in the LTP of NMDA EPSCs triggered by HFS, we
prevented D-serine synthesis with the serine racemase inhibitor
HOAsp, which has a lowmolecular weight (148 Da), allowing its
passage through gap junction channels and thus its diffusion
within the astroglial network (see also [Ca2]i clamp above). As a
first step, we performed dual recordings of a L5PC neuron in the
PFC with a pipette containing a standard solution; a nearby as-
trocyte was patched with a pipette solution containing HOAsp
(400 M). This approach resulted in a reduction of 7	 3% (n
7) of the NMDAEPSC amplitude. In addition, when the LTPwas
induced by HFS in L2/3, the potentiation of NMDA EPSCs was
reduced (Fig. 8). Indeed, in this set of experiments, NMDA
EPSCs were increased after HFS (Fig. 8A1,B) by 47 	 5% com-
pared with control (p 
 0.01, t test, n  7). When HOAsp was
infused within the astroglial network before HFS, the amplitude
of NMDA currents measured 30 min after HFS did not show a
4
(Figure legend continued.) 230 pS (n 5). D, All point histograms constructed from unitary
currents at negative (70 to30mV), positive (30 to50mV), and combined negative/
positive voltages. Single channel conductances are indicated above each peak of the distribu-
tions and were determined from the fitted Gaussian curves shown in yellow. Gap26 (red)
suppressed all unitary opening events and shifted the activity distribution to the closed state
(data from five different experiments).E, F, AverageQmdata for voltage steps to50mV (n
5). Asterisks indicate significant differences compared with the 50 nM [Ca 2]i condition;
hashtags indicate significant differences compared with the 200 nM [Ca 2]i condition (one
symbol p
 0.05; two symbols p
 0.01). All recordings were obtained from isolated replated
primary culture of astrocytes (see Materials and Methods).
Figure 6. LTP of NMDA synaptic currents in pyramidal cells depends on Cx43 hemichannel activation and [Ca 2]i in astrocytes.
LTP of NMDA synaptic currents in L5 was induced by HFS applied in L2/3 (see Materials and Methods and Fig. 1). A1–A3, Typical
average (n 5 consecutive traces) of NMDA EPSCs recorded at40 mV in presence of picrotoxin (100M) and NBQX (10M).
Scale bars, 100pAand100ms.A1, RepresentativeNMDAEPSCs recordedbefore (Control) and30minafterHFSprotocol.A2, NMDA
EPSCs recorded 30min after the HFS protocol and in presence of Gap26 (200M). A3, NMDA EPSCs recorded 30min after the HFS
protocol and after establishing a Ca 2 clamp in the astroglial network either without or in the presence of Gap26 (200M) in
Ca 2-clamp condition.B, Diagram showing the change over time in the amplitude of NMDAEPSCsmeasured before and after HFS
protocol in control (black), in the presence of a Ca 2 clamp of the astroglial network (red), and in the presence of Gap26 (blue).
C, Histogram showing the relative amplitude of NMDAEPSCsmeasured 30min after theHFS protocol ( p
0.05, t test,n7). The
LTPwas significantly reduced by either Ca 2 clampof the astroglial network or in the presence of Gap26 ( p 0.05, t test, n 8).
Note that combining Ca 2 clamp and the application of Gap26 has no additive effect ( p 0.05, t test, n 7).
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significant LTP (15	 3% compared with
the LTP control, p 0.05 compared with
HFS control, t test, n  7; Fig. 8A2,B).
Moreover, application of Gap26 did not
result in any additive effect on NMDA
current amplitude after HOAsp infusion
within the astroglial network (p  0.05
compared with the control HOAsp alone
after HFS, t test, n 7). Finally, the effect
of HOAsp infusion on the HFS induced
potentiation of NMDA currents was par-
tially rescued by adding D-serine (100
) in the extracellular solution (Fig.
8A3,B). Indeed, in the presence of extra-
cellular D-serine, HFS-induced LTP of
NMDA EPSCs (42	 2%) was statistically
increased compared with that recorded
with HOAsp only (p
 0.01, t test, n 7)
and close to the values recorded in control
condition (p 0.05, t test, n 7). There-
fore, as a whole, these data point to a role
of astroglial D-serine in themodulation of
NMDA-receptors activity that is associ-
ated with Cx43 hemichannel activity.
Discussion
In PFC pyramidal neurons, the amplitude
of NMDA, but not AMPA, synaptic cur-
rents triggered by the stimulation of L2/3
is reduced in presence of Gap26, a mi-
metic peptide that blocks Cx43 hemi-
channel activity. Because, in the brain,
Cx43 is expressed only in astrocytes dur-
ing the third week of mouse life, these
inhibitory effects reveal an astrocyte-to-
neuron interaction that affects glutama-
tergic transmission. Indeed, we show here
that Cx43 hemichannel activity is associated with the release of
D-serine by astrocytes that acts as an agonist of the glycine site of
neuronal NMDAR and contributes to LTP of NMDA and also
AMPA currents after HFS. Our results uncover a neuroglial dia-
log where a [Ca2]i-dependent Cx43 hemichannel function in
astrocytes is involved in the modulation of neuronal glutama-
tergic synaptic activity and plasticity.
The starting point of the present work is the observation that
Gap26 reduced the amplitude of NMDA EPSCs, whereas AMPA
EPSCs were not affected by this mimetic peptide. This observa-
tion indicates that Gap26 does not affect glutamate release in
neurons or uptake in astrocytes, but rather affects neuronal
NMDARs specifically. Gap26, which targets Cx43 (Wang et al.,
2012; see also Fig. 5), is expected to inhibit specifically astrocyte
hemichannels without any direct effect on neurons that do not
express Cx43 in 3-week-old mice, the age at which these exper-
iments were performed. Previous studies showed that astrocytes
are a source of D-serine in the brain (Schell et al., 1995;Wolosker
et al., 1999; but see Wolosker et al., 2016), that D-serine release
from astrocytes is [Ca2]i dependent and at least partially vesic-
ular (Mothet et al., 2005), and that glial D-serine acts on synaptic
NMDARs in PFC (Fossat et al., 2012). Based on these data, we
hypothesized that Cx43 hemichannel activity may be involved in
the process of D-serine release by astrocytes. This possibility was
corroborated by the fact that application of D-serine prevented the re-
duction of NMDA EPSCs by Gap26. This was also confirmed by
the fact that Gap26 had no additive effect on NMDA EPSCs am-
plitude when a serine racemase inhibitor, HOAsp, was infused
within the astroglial network before HFS. Although the specific-
ity of this inhibitor was questioned (Wolosker and Mori, 2012),
its reported effect on glutamate reuptake through transporters
can be excluded because NMDA currents were reduced, not in-
creased, in the present study. In addition, here, HOAsp was in-
troduced within astrocytes, which limits potential nonspecific
effects. Therefore, hemichannel activity contributes to D-serine
release by astrocytes. However, this does not necessarily mean
that Cx43 hemichannels provide the direct release pathway for a
cytosolic pool of D-serine. Indeed, opened hemichannels allow
for Ca2 influx (Schalper et al., 2010) that can amplify hemi-
channel activity (see above) and can also trigger [Ca2]i- and
SNARE protein-dependent vesicular release of D-serine by astro-
cytes (Martineau et al., 2013). However, the dissection of these
regulatory pathways goes beyond the scope of the present study
and this hypothesis remains to be investigated.
Cytoplasmic Ca2 controls hemichannel activity and previ-
ous works have shown that Cx43 hemichannel activity is charac-
terized by a bell-shaped “convex-up” response to changes in
[Ca2]i, with maximal activity in the 500 nM range and decreas-
ing activities at both higher and lower [Ca2]i. These findings
were based on ATP release and dye uptake studies in glioma cell
lines and other cell types (De Vuyst et al., 2009; De Bock et al.,
2012). Recently, single-channel studies of Cx43 hemichannels
Figure 7. LTP of AMPA synaptic currents in pyramidal cells depends on Cx43 hemichannel activation in astrocytes. LTP of AMPA
synaptic currents in L5was inducedbyHFSapplied in L2/3 (seeMaterials andMethods).A1,A2, Typical average (n5 consecutive
traces) of AMPA EPSCs recorded at70mV in presence of picrotoxin (100M). Scale bars, 100 pA and 100ms.A1, Representative
AMPA EPSCs recorded before (Control) and 30min after HFS protocol.A2, AMPA EPSCs recorded 30min after the HFS protocol and
in presence of Gap26 (200M). B, Diagram showing the change over time in the amplitude of AMPA EPSCs measured before and
after HFS protocol in control (black), in the presence of Gap26 (blue), and in the presence of the scrambled peptide (green).
C, Histogram showing the relative amplitude of AMPA EPSCs 30 min after HFS protocol ( p
 0.05, t test, n 7). The LTP was
significantly reduced by in presence of Gap26 ( p 0.05, t test, n 8), whereas the scrambled peptide had no significant effect
( p
 0.05, t test, n 7).
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confirmed these observations inHeLa cells transfected with Cx43
(Wang et al., 2012; Bol et al., 2017). Moreover, because Cx hemi-
channels are permeable to Ca2 (Sa´nchez et al., 2009; Schalper et
al., 2010; Fiori et al., 2012), their dependency on [Ca2]i contrib-
utes to a [Ca2]i-induced Ca
2 entry pathway. However, so far,
the information concerning a possible Ca2 dependence of Cx43
hemichannels was lacking for astrocytes. Therefore, we investi-
gated the activity of hemichannels in cultured astrocytes that
provide a single-cell system in which only Cx43, not Cx30, the
other astroglial Cx, is expressed (Giaume et al., 1991; Koulakoff et
al., 2008) and where astrocytes are not coupled together as they
are used at subconfluence. First, using EtBr uptake assays, we
were able to show that [Ca2]i increases generated by application
of ionomycin activate hemichannels, a process that was abolished
by either CBX or Gap26. Second, single-channel patch-clamp
recordings confirmed these observations and demonstrated that
an elevation of [Ca2]i to 200 nM activated Cx43 hemichannels
and that Gap26 inhibited them. Interestingly, their activity was
also recorded at very negative potentials similar to the resting
potential of astrocytes, as reported previously for cortical as-
trocytes treated either with proinflammatory cytokines or the
-amyloid peptide (Retamal et al., 2007; Orellana et al., 2011).
Based on these observations, our experiments of Ca2 clamp
performed in acute PFC slices can be interpreted as a situation in
which [Ca2]i is maintained at a low level, likely50–80 nM, as
indicated by Henneberger et al. (2010), and hemichannel activity
is limited.
The present study suggests an important role of astroglial
D-serine inmodulating NMDA receptor activity and thus synap-
tic plasticity in the PFC in a [Ca2]i-dependent manner. This
modulation also affected the LTP of AMPA EPSCs that was re-
duced in the presence of Gap26. This statement is in agreement
with the previous work of Henneberger et al. (2010), who re-
ported a [Ca2]i-dependent release of D-serine from astrocytes
controlling synaptic plasticity in the hippocampus. Importantly,
our study also provides novel evidence implyingCx43 hemichan-
nels in the D-serine neuroglial dialogue regulating neurotrans-
mission. For LTP induction, we used a classical theta-burst
stimulation protocol and clamped [Ca2]i close to its basal level.
These conditions differ from a recent work in CA1 hippocampal
neurons showing that induction of spike-timing-dependent LTP
was not affected in presence of BAPTA in astrocytes or slices
incubated with the astrogliotoxin fluoroacetate (Andrade-
Talavera et al., 2016). Such discrepancies in the contribution of
astrocytes in neuronal plasticity emphasize the importance of the
differences in protocols used to induce synaptic plasticity, the
brain region investigated, and the way to control [Ca2]i changes
(BAPTA vs EGTAlow Ca2) in astrocytes, which of course
involve different cellular and molecular events that can result or
not in the abovementioned neuroglial partnership.
There is increasing evidence that astrocyte Cxs contribute to
neuroglial interactions (Giaume et al., 2010; Pannasch and
Rouach, 2013). In the doubleCx43/Cx30KOmouse, inwhich the
two major astroglial Cxs are lacking, hippocampal synaptic
transmission and plasticity are affected due to modification in
extracellular homeostasis (Pannasch et al., 2011). Moreover,
Cx-mediated intercellular communication provides an astroglial
metabolic pathway that allows the trafficking of energy substrates
from the glio–vascular interface to the synapses and contributes
to synaptic activity (Giaume et al., 2010). Conversely, whereas
astrocyte hemichannels were initially thought to operate exclu-
sively in inflammatory situations or in pathological contexts
(Bennett et al., 2012), their contribution was demonstrated in
tanycytes treated with glucose and in HeLa cells transfected with
various Cxs treated with FGF-1 (Schalper et al., 2008). In addi-
tion, when studied in basal conditions either in the hippocampus
(Chever et al., 2014) or in the olfactory bulb (Roux et al., 2015),
astroglial Cx43 hemichannel activity affects the excitatory synap-
tic transmission and slow oscillations, respectively. Interestingly,
in both cases, ATP/adenosine signaling linked to Cx43 hemi-
channel activity in astrocytes was responsible for the changes in
these neuronal properties. Moreover, in vivo evidence indicates
that gliotransmission linked to Cx43 hemichannels is necessary
for fear memory consolidation at the rat basolateral amygdala
with a possible contribution ofD-serine (Stehberg et al., 2012). In
the present study, we provide for the first time evidence that
astrocyte Cx43 hemichannels are involved in the acute and long-
term modulation of glutamatergic EPSCs through D-serine re-
lease by astrocytes of the PFC. Therefore, the contribution of
Cx43 hemichannels to gliotransmission would not only bemedi-
Figure 8. D-serine release by astrocytes requires Cx43 hemichannel activation to induce LTP
of NMDA EPSCs in PFC pyramidal neurons. A1–A3, Typical average (n 5 consecutive traces)
NMDA EPSCs recorded at40 mV in the presence of picrotoxin (100M) and NBQX (10M).
Scale bars, 100 pA and 100 ms. A1, Representative NMDA EPSCs recorded before (Control) and
30min after theHFS protocol.A2, NMDAEPSCs recorded 30min after theHFS protocol and after
infusion of a serine-racemase inhibitor (HOAsp, 400M) in the astroglial network. A3, NMDA
EPSCs recorded 30 min after the HFS protocol and after infusion of HOAsp in the astroglial
network plus D-serine (100M) in the extracellular solution. C, Summary diagram showing a
significant increase of NMDA EPSC amplitude 30 min after the HFS protocol ( p
 0.01, t test,
n 7) that is prevented after infusion of HOAsp in the astroglial network ( p 0.05, t test,n
7) and partially rescued by adding D-serine (100M) in the bath solution (vs HFS p
 0.05,
t test, n 7).
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ated by ATP (Kang et al., 2008) and glutamate (Ye et al., 2003;
Abudara et al., 2015), but also byD-serine, showing their key role
in the modulation of synaptic function. This may be particularly
relevant in brain structures where D-serine and serine racemase
are known to be present at a relatively high concentration, such as
in the PFC (Hashimoto et al., 1995; Fossat et al., 2012).
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